BioElectronics Announces Expanded Menstrual Pain Study

FREDERICK, MD, Jan. 16, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce the commencement of an independent clinical study to investigate the efficacy of the Allay® Menstrual Pain device. The study will be take place at the prestigious United Kingdom Birmingham Women’s NHS Foundation Trust.

Primary dysmenorrhea (menstrual pain) is the most common women’s health problem. 28% of women are in the menstruating phase of life and 60% have monthly pain and discomfort that can negatively impact work productivity, cognitive performance, and quality of life. Allay Menstrual Pain Therapy provides drug free affordable 24-hour relief for less than $1.00 per day.

The principal investigator is Professor T. Justin Clark, MD (hons) FRCOG. Dr. Clark and his team are renowned researchers in women’s health. This expanded menstrual pain study will involve 60 women who currently suffer with menstrual pain, and is designed to span two menstruation cycles for each subject. Enrollment has been completed and the study is expected to be finished in August of this year. The results will also be used to support a grant funding application in the United Kingdom to conduct a larger multi-center clinical study. Additional details about the study can be found at the NIH’s clinical trials listing page: https://clinicaltrials.gov/ct2/show/NCT03394547?cond=Menstrual+Pain&cntry=GB&rank=1

“Women should have safe, drug-free menstrual pain therapy options like the nonprescription Allay in view of the growing evidence on the side effects of over-the-counter and prescription pain medications. This UK randomized, double-blinded placebo-controlled trial will allow us to gain US FDA market clearance, broader market acceptance, and a better understanding of the mechanism of action for this product”, said Dr. Ian Rawe, Ph.D., Director of Clinical Research at BioElectronics.

About BioElectronics Corporation

BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy. For more information, please visit us at www.bielorp.com
Contact:
Paul Knopick
940 262 3584
pknopick@eandecommunications.com

Comments are closed.